Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Efgartigimod”

75 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 75 results

Large-scale testing (Phase 3)Not Yet RecruitingNCT07231523
What this trial is testing

EFG vs IVIG in TAMG

Who this might be right for
EfgartigimodIntravenous ImmunoglobulinMyasthenia Gravis Associated With Thymoma
Shanghai Zhongshan Hospital 64
Testing effectiveness (Phase 2)Study completedNCT06203457
What this trial is testing

Open-Label Extension Study to Evaluate the Safety of Efgartigimod in Adult Patients With Primary Sjögren's Syndrome

Who this might be right for
Primary Sjögren's Syndrome
argenx 24
Large-scale testing (Phase 3)Looking for participantsNCT06765161
What this trial is testing

Efgartigimod in IVIG Dependent Myasthenia Gravis Patients

Who this might be right for
Myasthaenia Gravis
Clinique Neuro-Outaouais 30
Large-scale testing (Phase 3)Looking for participantsNCT07194850
What this trial is testing

Efgartigimod IV in Participants From 12 Years to Less Than 18 Years of Age With Chronic Immune Thrombocytopenia (ITP)

Who this might be right for
Immune Thrombocytopenia (ITP)ITP - Immune ThrombocytopeniaITP+4 more
argenx 24
Not applicableUnknownNCT06118398
What this trial is testing

Efgartigimod in Acute Neuromyelitis Optica Spectrum Disorders

Who this might be right for
Neuromyelitis OpticaEfgartigimod
Feng Jinzhou 24
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07806916
What this trial is testing

Efficacy and Safety of Efgartigimod in the Treatment of Guillain-Barré Syndrome(GREAT)

Who this might be right for
Guillain-Barré Syndrome
Beijing Tiantan Hospital 110
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07583641
What this trial is testing

Learn About How Well the Medicine Efgartigimod Works to Treat Autoimmune Encephalitis In Children 12 Years or Older and Adults

Who this might be right for
Autoimmune Encephalitis (AE)
argenx 170
Early research (Phase 1)Study completedNCT04564066
What this trial is testing

Compare the Safety and Effect of Efgartigimod as an Intravenous Infusion With the Effect of Efgartigimod as a Subcutaneous Injection in Healthy Volunteers

Who this might be right for
Healthy Volunteers
argenx 54
Large-scale testing (Phase 3)Active Not RecruitingNCT06558279
What this trial is testing

Assess Efficacy and Safety of Efgartigimod PH20 SC in Adults With Ocular Myasthenia Gravis

Who this might be right for
Myasthenia Gravis, Ocular
argenx 141
Large-scale testing (Phase 3)Study completedNCT04687072
What this trial is testing

Evaluate the Efficacy and Safety of Efgartigimod PH20 Subcutaneous in Adult Patients With Primary Immune Thrombocytopenia

Who this might be right for
Primary Immune Thrombocytopenia
argenx 207
Testing effectiveness (Phase 2)Active Not RecruitingNCT04280718
What this trial is testing

Assess the Long-term Safety and Efficacy of a Subcutaneous Formulation of Efgartigimod in Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP, an Autoimmune Disorder That Affects the Peripheral Nerves)

Who this might be right for
Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
argenx 229
Large-scale testing (Phase 3)Looking for participantsNCT06544499
What this trial is testing

Assess the Efficacy and Safety of Efgartigimod IV in Adult Participants With Primary Immune Thrombocytopenia

Who this might be right for
Primary Immune Thrombocytopenia (ITP)
argenx 69
Early research (Phase 1)Study completedNCT04073589
What this trial is testing

Efgartigimod Co-administered Subcutaneously With rHuPH20 in Healthy Subjects

Who this might be right for
Healthy Volunteers
argenx 33
Early research (Phase 1)Study completedNCT05163834
What this trial is testing

Immune Response to PNEUMOVAX 23 in Healthy Adults Receiving Efgartigimod IV

Who this might be right for
Healthy Volunteers
argenx 36
Testing effectiveness (Phase 2)Ended earlyNCT05810961
What this trial is testing

Assess Effectiveness and Safety of Efgartigimod in Chinese Patients with Primary Membranous Nephropathy (ZL-1103-014)

Who this might be right for
Membranous Nephropathy
argenx 8
Testing effectiveness (Phase 2)Looking for participantsNCT07673744
What this trial is testing

Evaluate the Efficacy and Safety of Maintenance Ublituximab Following Induction With Efgartigimod Administration in Participants With Myasthenia Gravis (MG)

Who this might be right for
Myasthenia Gravis
TG Therapeutics, Inc. 120
Not applicableNot Yet RecruitingNCT06827587
What this trial is testing

Efficacy and Safety of Efgartigimod Sequential Therapy with Telitacicept in Generalized Myasthenia Gravis

Who this might be right for
Myasthenia GravisAutoimmune DiseasesNeuromuscular Diseases
First Affiliated Hospital of Wenzhou Medical University 60
Large-scale testing (Phase 3)Ended earlyNCT06307626
What this trial is testing

Efgartigimod PH20 SC Given by Prefilled Syringe in Adults With Thyroid Eye Disease.

Who this might be right for
Thyroid Eye Disease
argenx 105
Large-scale testing (Phase 3)Not Yet RecruitingNCT06885762
What this trial is testing

Efgartigimod for the Treatment of Guillain-Barré Syndrome

Who this might be right for
Guillain-Barre Syndrome (GBS)
Zhongming Qiu 20
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06221501
What this trial is testing

Perioperative Efgartigimod for Thymoma and Myasthenia Gravis

Who this might be right for
Myasthenia Gravis
Shanghai Zhongshan Hospital 30
Next Page